Raymond James Financial Services Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,670	Closed	-$276K	–	3237
2023 Q1	$276K	Hold	14,670	–	–	﹤0.01%	2700
2022 Q4	$234K	Buy	+14,670	New	+$229K	﹤0.01%	2763
2022 Q2	–	Sell	-23,611	Closed	-$572K	–	3257
2022 Q1	$572K	Buy	+23,611	New	+$571K	﹤0.01%	2303
2021 Q3	–	Sell	-11,234	Closed	-$274K	–	3288
2021 Q2	$274K	Buy	11,234 +1,002	+10%	+$22.6K	﹤0.01%	2786
2021 Q1	$264K	Sell	10,232 -5,533	-35%	-$244K	﹤0.01%	2710
2020 Q4	$843K	Buy	15,765 +9,146	+138%	+$454K	﹤0.01%	1804
2020 Q3	$273K	Buy	6,619 +78	+1%	+$3.37K	﹤0.01%	2328
2020 Q2	$317K	Sell	6,541 -1,657	-20%	-$79.5K	﹤0.01%	2200
2020 Q1	$346K	Sell	8,198 -3,893	-32%	-$160K	﹤0.01%	1766
2019 Q4	$517K	Buy	12,091 +3,150	+35%	+$137K	﹤0.01%	1961
2019 Q3	$322K	Buy	+8,941	New	+$271K	﹤0.01%	2200
2018 Q3	–	Sell	-39,372	Closed	-$601K	–	2811
2018 Q2	$601K	Sell	39,372 -496	-1%	-$8.84K	﹤0.01%	1753
2018 Q1	$896K	Sell	39,868 -10,620	-21%	-$294K	0.01%	1373
2017 Q4	$1.52M	Buy	50,488 +2,256	+5%	+$72.1K	0.01%	1034
2017 Q3	$1.82M	Buy	48,232 +2,325	+5%	+$75.6K	0.01%	961
2017 Q2	$1.28M	Buy	45,907 +8,006	+21%	+$239K	0.01%	1110
2017 Q1	$1.3M	Sell	37,901 -5,844	-13%	-$206K	0.01%	1029
2016 Q4	$1.26M	Sell	43,745 -13,761	-24%	-$364K	0.01%	993
2016 Q3	$1.83M	Sell	57,506 -8,600	-13%	-$292K	0.02%	816
2016 Q2	$2.15M	Buy	66,106 +16,865	+34%	+$564K	0.02%	702
2016 Q1	$1.38M	Buy	49,241 +7,605	+18%	+$166K	0.02%	773
2015 Q4	$1.48M	Buy	41,636 +28,225	+210%	+$994K	0.02%	762
2015 Q3	$444K	Buy	+13,411	New	+$558K	0.01%	1106